Institute for Global Health, University College London, London, UK
Institute for Global Health, University College London, London, UK.
BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2020-004793.
In February 2020, Nigeria faced a potentially catastrophic COVID-19 outbreak due to multiple introductions, high population density in urban slums, prevalence of other infectious diseases and poor health infrastructure. As in other countries, Nigerian policymakers had to make rapid and consequential decisions with limited understanding of transmission dynamics and the efficacy of available control measures. We present an account of the Nigerian COVID-19 response based on co-production of evidence between political decision-makers, health policymakers and academics from Nigerian and foreign institutions, an approach that allowed a multidisciplinary group to collaborate on issues arising in real time. Key aspects of the process were the central role of policymakers in determining priority areas and the coordination of multiple, sometime conflicting inputs from stakeholders to write briefing papers and inform effective national decision making. However, the co-production approach met with some challenges, including limited transparency, bureaucratic obstacles and an overly epidemiological focus on numbers of cases and deaths, arguably to the detriment of addressing social and economic effects of response measures. Larger systemic obstacles included a complex multitiered health system, fragmented decision-making structures and limited funding for implementation. Going forward, Nigeria should strengthen the integration of the national response within existing health decision bodies and implement strategies to mitigate the social and economic impact, particularly on the poorest Nigerians. The co-production of evidence examining the broader public health impact, with synthesis by multidisciplinary teams, is essential to meeting the social and public health challenges posed by the COVID-19 pandemic in Nigeria and other countries.
2020 年 2 月,由于多次传入、城市贫民窟人口密度高、其他传染病流行和卫生基础设施薄弱,尼日利亚面临着 COVID-19 疫情大爆发的潜在风险。和其他国家一样,尼日利亚政策制定者在对传播动态和现有控制措施的效果缺乏了解的情况下,必须迅速做出重大决策。我们根据尼日利亚和外国机构的政治决策者、卫生政策制定者和学者之间的证据共同制定,描述了尼日利亚 COVID-19 应对措施,这种方法允许多学科小组实时合作解决出现的问题。该过程的关键方面是政策制定者在确定优先领域以及协调来自利益攸关方的多个有时相互冲突的投入方面的核心作用,这些投入用于编写简报文件并为有效的国家决策提供信息。然而,共同制定方法也遇到了一些挑战,包括透明度有限、官僚障碍以及过于关注病例和死亡人数的流行病学,这可能会损害应对措施的社会和经济影响。更大的系统性障碍包括复杂的多层次卫生系统、分散的决策结构以及实施工作的资金有限。未来,尼日利亚应加强国家应对措施在现有卫生决策机构内的整合,并实施减轻社会和经济影响的战略,特别是对最贫穷的尼日利亚人。多学科团队进行的更广泛的公共卫生影响的证据共同制定对于应对 COVID-19 大流行在尼日利亚和其他国家带来的社会和公共卫生挑战至关重要。